Effects of Omega-3 Fatty Acids on the Human Gene Expression

NCT01089231 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-12-19

Study results available
· View outcomes & findings →

Summary

The aim of this study is to investigate the effects of short- and long-term intervention with EPA and DHA-rich fish oil on gene expression profiles in healthy and hyperlipidemic males.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish oil

Dietary Supplement: fish oil capsules (6 per day) 3024 mg n-3 fatty acids daily (1512 mg EPA and 1008 mg DHA) about 3 months

DIETARY_SUPPLEMENT

Placebo (corn oil)

corn oil (6 capsules per day)

Sponsors & Collaborators

  • Gottfried Wilhelm Leibniz Universität Hannover

    lead OTHER

Principal Investigators

  • Andreas Hahn, Prof. · Gottfried Wilhelm Leibniz University of Hanover

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
51 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-07-31
Completion
2011-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089231 on ClinicalTrials.gov